Juárez SG

Language: Spanish
References: 14
Page: 32-34
PDF size: 32.88 Kb.

ABSTRACT

The objective of the present study is to determine the effectiveness in treatment with infrared rays and interference current in the handling of pain secondary to diabetic polyneuropathy in elderly patients. Twenty elderly patients were studied, an initial valuation was made with the help of questioning about the polyneuropathy characteristics, pattern of pain, as well as valuation of intensity of it through analogous visual pain scale (AVP), magnitude of pain was classified in three categories: low, moderate and severe, rehabilitation therapy was used during 20 sessions putting in to peripheral nerves. In relation with the results it was found the following: 66.10 average age, pattern of diabetic, 5 elderly patients were insulinorequires and 15 elderly patients were not. The pattern of disease was sensorial in 8 patients and 12 patients in motor and sensorial disease, the most frequently disease segment was in pelvic parts, 1 patient in thoracic parts and 1 patient in putting in intercostal way. The quantity of therapeutic applications was of 16.5 (therapy sessions). The final result shows up 14 patients with excellent improvement, 4 patients with regular improvement and 2 patients without improvement. The Wilcoxon test shows up a value of p =.0001, relating to pain that was of 7.45 points before the intervention, decreasing to 2.70 points in the analogous visual pain scale after the treatment. According to the above mentioned, Rehabilitation Medicine can constitute a therapeutic alternative to handle pain in elderly patients with polyneuropathy secondary to diabetic mellitus besides helping to reduce polypharmacy in those patients.

REFERENCES

1. Hazzard RW, Blass PJ et al. Principies of geriatrics medicina and Gerontology. Fourth Edition. McGraw-Hill, 991.

2. Ariza R, Frati AM y cols. Diabetes mellitus, neuropatía diabética. Número 7 Actualidades en Medicina Interna.

3. Kauffman Timothy L et al. Geriatic Rehabilitation Manual, 1st ed. Churchill Livingstone año y p.

4. Backonja misha-Miroslava. Clínicas Neurológicas de Norteamérica, editorial McGraw-Hill-Interamericana. 1998: 4.

5. Galer BS, Jensen M. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology 1997; 48: 332-339.

6. Peripheral Neuropathy Association: Quantitative sensory testing: A consensous report from de peripheral Neuropathy Association. Neurology 1993, 43: 1050-1052.

7. Melton LJ, Dick PJ. Epidemiology. In Dick Pj. Thomas A, Asbury A et al (eds): Diabetics Neuropathy. Philadelphia, WB Saunders Company 1987: 27-35.

8. Galler Bs Neuropathy. Amer P Soc Bulletin Octuber/November 1993: 18-19.

9. Servicio de epidemiología Hospital General de Zona No 27 IMSS “Dr. Alfredo Badallo Garcia” con datos de ARIMAC 98.

10. Ziegler D, Gries FA, Spuler M et al. The epidemiology of diabetic neuropathy. J Diabetes Complication 1992; 6: 49-57.

11. Gómez-Pérez FJ, Rull JA, Dies H et al. Nortriptilyne and Fluphnazine in the symptomatic treatment of diabetes neuropathic.

12. Simonnet J. Kinesiterapia, medicina física, encicyclopédie médico chirurgicale, Elsevier Paris Francia.

13. DeLisa JA. Rehabilitación Medicine. Principles and Practice, JB. Lippincott.

14. Wall PD, Melzack R. Textbook of pain. Third. Edition. Churchill Livinstone 1994.